Cyclosporine 0.05% Eye Drops for Vernal Keratoconjunctivitis Trial

Conditions:   Vernal Keratoconjunctivitis;   Cyclosporine 0.05% Eye Drops Interventions:   Drug: Cyclosporine 0.05% eye drops;   Drug: Loteprednol Etabonate 0.5% and Tobramycin Eye Drops 0.3% Sponsor:   Second Affiliated Hospital of Nanchang University Completed

Source: ClinicalTrials.gov - April 29, 2022 Category: Research Source Type: clinical trials